<DOC>
	<DOCNO>NCT00420862</DOCNO>
	<brief_summary>High survival rate report screen-detected Stage I lung cancer patient , concern potential bias uncontrolled study . DANTE prospective randomize control trial explore effect screen LDCT lung-cancer-specific mortality , prevalence incidence rate lung cancer , stage distribution resectability rate select high-risk population . The prevalence set biomarkers sputum blood sample also determine .</brief_summary>
	<brief_title>The DANTE Trial . A Randomized Study Lung Cancer Screening With Low-Dose Spiral Computed Tomography</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Male sex Age 6074 year smokers 20 cigarettes/day least 20 year ( actual smoker exsmokers 10 year ) severe cardiopathy advanced BPCO chronic hypoxaemia ( rest SatO2 &lt; 94 % ) chronic severe renal insufficiency hypertension control drug type 2 diabetes severe systemic disease severe previous cerebrovascular lesion permanent invalidity ( selfsufficient ) . severe vascular lesion repeat ictus , trophic lesion , limb loss , actual smoker Dementia , psychosis , severe depression maniacdepressive syndrome actual precedent neoplasia , except skin tumor notmelanoma scaly cell laryngeal buccal cavity tumor , N0 , recover 10 year tumor recover 10 year transplantation less 5 year rejection episode last 2 year unable subject</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Lung neoplasm</keyword>
	<keyword>Early diagnosis</keyword>
	<keyword>Screening</keyword>
	<keyword>Spiral Computed Tomography</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>